These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8795587)

  • 1. Forty years of repeated screening: the significance of carcinoma in situ.
    Morrison BJ; Coldman AJ; Boyes DA; Anderson GH
    Br J Cancer; 1996 Sep; 74(5):814-9. PubMed ID: 8795587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of a Pap smear program and suggestions for its implementation.
    Boyes DA
    Cancer; 1981 Jul; 48(2 Suppl):613-21. PubMed ID: 7272982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85.
    Anderson GH; Boyes DA; Benedet JL; Le Riche JC; Matisic JP; Suen KC; Worth AJ; Millner A; Bennett OM
    Br Med J (Clin Res Ed); 1988 Apr; 296(6627):975-8. PubMed ID: 3129115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
    van Oortmarssen GJ; Habbema JD
    Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of regular 3-yearly screening on the incidence of cervical smears: the Leiden experience.
    Boon ME; de Graaff Guilloud JC; Rietveld WJ; Wijsman-Grootendorst A
    Cytopathology; 1990; 1(4):201-10. PubMed ID: 2101670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening. Past success and future challenge.
    Dewar MA; Hall K; Perchalski J
    Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
    Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in cancer of the cervix uteri in Sweden following cytological screening.
    Bergström R; Sparén P; Adami HO
    Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status.
    Mitchell HS
    Cancer; 2001 Aug; 93(4):237-40. PubMed ID: 11507695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study.
    Mitchell H; Hocking J; Saville M
    Acta Cytol; 2004; 48(5):595-600. PubMed ID: 15471249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of physical findings in diagnosis of cervical carcinoma.
    Moller KA; Fogh H; Moller PE; Strandbygard K
    Dan Med Bull; 1972 Jun; 19(4):122-7. PubMed ID: 5041568
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation.
    Gustafsson L; Adami HO
    Br J Cancer; 1990 Jun; 61(6):903-8. PubMed ID: 2372495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Screening for cervical cancer.
    Lancet; 1974 Jun; 1(7868):1221. PubMed ID: 4134347
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of cervical cancer after a negative Pap smear.
    Viikki M; Pukkala E; Hakama M
    J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women with positive cervical smears but without surgical intervention. A follow-up study.
    Kinlen LJ; Spriggs AI
    Lancet; 1978 Aug; 2(8087):463-5. PubMed ID: 79818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive program for cervical cancer detection and management.
    Benedet JL; Anderson GH; Matisic JP
    Am J Obstet Gynecol; 1992 Apr; 166(4):1254-9. PubMed ID: 1566781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.